Gufic Biosciences Ltd. benchmarking: Performance to industry peers

Financial

	Gufic Biosciences	Novartis India	Panacea Biotec
Operational Metrics
Pharmaceuticals
R&D as a % of Total Sales	1.28 %	n/a	9.86 %
Financials
5 yr Average ROE	16.89 %	8.11 %	37.52 %
5yr average Equity Multiplier	2.16	2.72	0.36
5yr Average Asset Turnover Ratio	0.75	0.18	0.41
5yr Avg Net Profit Margin	10.24 %	17.12 %	26.1 %
Price to Book	5.43	4.34	4.11
P/E	56.24	38.12	0.0
5yr Avg Cash Conversion Cycle	-15.25 Days	-23.33 Days	-170.26 Days
Inventory Days	71.73 Days	44.27 Days	120.03 Days
Days Receivable	106.89 Days	38.18 Days	42.2 Days
Days Payable	179.29 Days	124.28 Days	325.14 Days
5yr Average Interest Coverage Ratio	8.9	65.43	2.7
5yr Avg ROCE	17.89 %	5.91 %	-2.79 %
5yr Avg Operating Profit Margin	18.12 %	15.15 %	-3.85 %
5 yr average Debt to Equity	0.67	0.0	-0.69
5yr CAGR Net Profit	-2.66 %	37.01 %	-43.68 %
5yr Average Return on Assets	7.7 %	3.13 %	9.32 %
Shareholdings
Promoter Holding	72.5 %	70.68 %	72.48 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-2.5 %	0.0	-1.11 %
Change in Mutual Fund Holding (3 Yrs)	2.6 %	0.0	0.0

	Gufic Biosciences	Novartis India	Panacea Biotec
Product Wise Break-Up	Product Wise Break-Up Domestic Pharmaceuticals 50.0 CMO 30.0 International 15.0 Active Pharmaceutical Ingredient (API) 5.0 Muscle Relaxants 0 Cardiovascular 0 Proton pump inhibitors 0 Anti-fungals 0 Anti-bacterials 0 0 Research and Development 0 Formulations 0 Vaccines 0	Product Wise Break-Up Research and Development 0 Anti-fungals 0 Domestic Pharmaceuticals 0 Active Pharmaceutical Ingredient (API) 0 International 0 Anti-bacterials 0 Muscle Relaxants 0 CMO 0 Formulations 0 Proton pump inhibitors 0 Vaccines 0 Cardiovascular 0 Wholesale of pharmaceuticals and medical goods 100.0	Product Wise Break-Up Research and Development 0 Anti-fungals 0 Domestic Pharmaceuticals 0 Active Pharmaceutical Ingredient (API) 0 International 0 Anti-bacterials 0 Muscle Relaxants 0 CMO 0 Formulations 39.92 Proton pump inhibitors 0 Vaccines 60.08 Cardiovascular 0 0
Location Wise Break-Up	Location Wise Break-Up India 79.83 Europe 7.54 Asia Pacific 6.04 Africa 2.95 South America 2.37 North America 1.19 Australia 0.08 Rest of the World 0	Location Wise Break-Up Europe 0 South America 0 Africa 0 India 100.0 Asia Pacific 0 North America 0 Rest of the World 0 Australia 0	Location Wise Break-Up Europe 0 South America 0 Africa 0 India 13.91 Asia Pacific 0 North America 0 Rest of the World 86.09 Australia 0